On Jan. 3, the U.S. Food and Drug Administration authorized COVID-19 booster shots for ages 12-15. Citing lab studies and Israeli data, the FDA has shortened the time frame between completion of the primary vaccination series with the Pfizer-BioNTech shot — the only one authorized for anyone 12 and older — and when someone can get a booster to at least five...
This content is restricted to members.
